Seres Therapeutics Inc (MCRB)

Seres Therapeutics Inc (MCRB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $29.5M; returns 1 day -1.9%, 1 week -15.0%, 1 year -88.2%.

Seres Therapeutics Inc. (MCRB) is a clinical-stage biotechnology company focused on developing novel live biotherapeutics (LBPs) designed to treat diseases by modulating the human microbiome. The company historically pioneered and achieved the first FDA approval for VOWST™ (formerly SER-109), an orally administered microbiome therapeutic for recurrent Clostridioides difficile infection (CDI).

Groups MCRB belongs to

• Biotechnology
• Clinical Stage Biotech
• Life Sciences
• Infectious Diseases
• Biopharmaceutical
• Fast Track Designation
• Healthcare

MCRB financial model: income statement, cash flow and balance sheet